ADVERTISEMENT
An artist’s rendering of a DNA-based virus trap, represented as gray rods in a short cone-shaped arrangement. One is coated with blue molecules, likely antibodies, that adhere to a virus target. Another image shows to traps coming together to capture a red coronavirus.
“Origami” DNA Traps Could Keep Large Viruses From Infecting Cells
By engineering structures out of DNA, scientists could potentially prevent larger viruses, like coronaviruses and influenza viruses, from interacting with cells.
“Origami” DNA Traps Could Keep Large Viruses From Infecting Cells
“Origami” DNA Traps Could Keep Large Viruses From Infecting Cells

By engineering structures out of DNA, scientists could potentially prevent larger viruses, like coronaviruses and influenza viruses, from interacting with cells.

By engineering structures out of DNA, scientists could potentially prevent larger viruses, like coronaviruses and influenza viruses, from interacting with cells.

SARS-CoV-2
Illustration of viruses represented with different colors overlapping each other.
What Happens When You Catch More than One Virus?
Alejandra Manjarrez, PhD | Dec 7, 2022 | 8 min read
The “tripledemic” shines a spotlight on viral interference, in which one infection can block another.
Image of a white cardboard box with a blue vertical stripe on the left side, the word “Apixaban” in blue lettering at the bottom, and a depiction of apixaban’s molecular structure in black.
Blood Thinner Ineffective for COVID-19 Patients: Study
Dan Robitzski | Nov 28, 2022 | 2 min read
A clinical trial finds that the anticoagulant apixaban, which has been prescribed to help COVID-19 patients recover, is ineffective and in rare instances dangerous.
3D medical illustration of peripheral blood cells: a lymphocyte (left) and a monocyte (right) surrounded by red blood cells.
PBMCs: Mononucleated and Multipurposed
Deanna MacNeil, PhD | 4 min read
Researchers employ peripheral blood mononuclear cells (PBMCs) in clinical and academic applications related to the immune system and regenerative medicine.
A brown and gray Daubenton’s bat in midair, flying in the general direction of the camera with wings outstretched and mouth open.
Duplicated Gene Helps Bats Survive “Arms Race” With Viruses
Dan Robitzski | Nov 23, 2022 | 5 min read
Bats are known for staying healthy even while harboring viral infections. Now, research sheds light on how their unusual immune system evolved.
close-up photo of fruit fly on white background
Scientists ID Heart-Damaging SARS-CoV-2 Protein
Grace van Deelen | Nov 22, 2022 | 3 min read
In flies and mice, a viral protein increases the rate of energy use by heart cells. But it’s not yet clear if the finding applies to humans.
Learn how researchers develop novel vaccines with new technologies 
The Vaccine Journey: From Bench to Needle
Bio-Rad | 1 min read
Researchers build better vaccines thanks to innovative technology.
hundred-dollar bills disintegrating
FTX Collapse Imperils Philanthropic Research Funding
Shawna Williams | Nov 15, 2022 | 2 min read
Natural science research projects were among those promised funding by the now-collapsed crypto exchange’s “effective altruism” foundations.
Illustration of SARS-CoV-2
US Agency to Look into Project on Modified Coronavirus
Catherine Offord | Oct 18, 2022 | 3 min read
The National Institute of Allergy and Infectious Diseases was not aware that the work involved a chimeric strain of SARS-CoV-2, STAT reports.
COVID-19: Lessons Learned
COVID-19: Lessons Learned
The Scientist Creative Services Team | 2 min read
An expert panel will discuss what researchers have learned from the COVID-19 pandemic and what lessons remain for the future. 
several blue office chairs sit empty in a carpeted room, with a paper sign saying "Vaccination centre welcome" pasted on the white wall above. 
Is a Winter COVID-19 Case Surge Coming?
Katherine Irving | Oct 17, 2022 | 3 min read
Low booster rates and immune-evading SARS-CoV-2 variants could spell bad news, experts say. 
A person in a white shirt activates a nasal spray
Oxford-AstraZeneca Nasal COVID-19 Vaccine Falters in Clinical Trial
Dan Robitzski | Oct 11, 2022 | 2 min read
Researchers say they’re abandoning the project in its current form—one of several that aims to induce what’s known as mucosal immunity against SARS-CoV-2.
Exploring the SARS-CoV-2 Outer Cell Surface
Exploring the SARS-CoV-2 Outer Cell Surface: Lessons in Innate and Adaptive Immunity
The Scientist Creative Services Team | 1 min read
In this webinar, Alberto Lopez-Munoz will discuss SARS-CoV-2 nucleocapsid protein cell surface expression and its role in host immunity.
News feature
Vector image of black body with head surrounded by white clouds
Multiple Possible Causes of Long COVID Come into Focus
Natalia Mesa, PhD | Sep 28, 2022 | 10+ min read
Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  
Artist&rsquo;s rendition of <em>Meraxes gigas</em>&rsquo;s head
Caught on Camera
The Scientist Staff | Sep 12, 2022 | 2 min read
See some of the coolest images recently featured by The Scientist
GENETIC PREDISPOSITION TO VITAMIN D DEFICIENCY CONTRIBUTES TO SEVERE COVID-19
Genetic Predisposition to Vitamin D Deficiency Contributes to Severe COVID-19
Iris Kulbatski, PhD | 4 min read
Ana Teresa Freitas discusses how individual variation in vitamin D synthesis and metabolism influences susceptibility to upper respiratory viruses.
A surgical mask next to an open pill bottle that&rsquo;s toppled over, spilling out red capsules meant to represent vitamin D supplements.
Vitamin D Likely Doesn’t Prevent COVID-19, Studies Find
Dan Robitzski | Sep 9, 2022 | 2 min read
The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.
the Melbourne skyline with lake in foreground
New Australian Center Will Develop Therapies for Future Pandemics
Shawna Williams | Aug 31, 2022 | 2 min read
Launched with a $172 million philanthropic donation and funds from the state of Victoria, the Melbourne-based research institute aims to construct drug discovery platforms to speed the introduction of new therapies.
A New Multiplexed SARS-CoV-2 Serological Assay Using Advanced Flow Cytometry
A New Multiplexed SARS-CoV-2 Serological Assay Using Advanced Flow Cytometry
The Scientist Creative Services Team | 1 min read
Julie Lovchik will discuss how advanced flow cytometry instrumentation facilitates multiplex assessment of IgG, IgM, and IgA antibodies against SARS-CoV-2.
Small vaccine bottles on a conveyer belt
Pfizer and Moderna COVID-19 Omicron Boosters Get OK from the FDA
Catherine Offord | Aug 31, 2022 | 3 min read
The immunizations are designed to target the latest Omicron subvariants, and are only authorized for people who have already received their primary vaccinations.
ADVERTISEMENT